"Chelation Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body.
| Descriptor ID |
D015913
|
| MeSH Number(s) |
E02.319.155
|
| Concept/Terms |
Chelation Therapy- Chelation Therapy
- Therapy, Chelation
- Chelation Therapies
- Therapies, Chelation
|
Below are MeSH descriptors whose meaning is more general than "Chelation Therapy".
Below are MeSH descriptors whose meaning is more specific than "Chelation Therapy".
This graph shows the total number of publications written about "Chelation Therapy" by people in this website by year, and whether "Chelation Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chelation Therapy" by people in Profiles.
-
Pattern of complications and burden of disease in patients affected by beta thalassemia major. Curr Med Res Opin. 2017 08; 33(8):1525-1533.
-
Relation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years. Leuk Res. 2017 05; 56:88-95.
-
Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients. Transfusion. 2016 07; 56(7):1707-15.
-
The Italian multiregional thalassemia registry: Centers characteristics, services, and patients' population. Hematology. 2016 Aug; 21(7):415-24.
-
Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy. Pediatr Blood Cancer. 2014 Dec; 61(12):2319-20.
-
Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry. Leuk Res. 2014 Feb; 38(2):149-54.
-
Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration. Neurobiol Dis. 2010 Feb; 37(2):307-13.
-
Role of iron in neurotoxicity: a cause for concern in the elderly? Curr Opin Clin Nutr Metab Care. 2009 Jan; 12(1):22-9.